Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26


The combined effect of high pressure processing and dimethyl dicarbonate to inactivate foodborne pathogens in apple juice.

Petrus RR, Churey JJ, Humiston GA, Cheng RM, Worobo RW.

Braz J Microbiol. 2019 Aug 26. doi: 10.1007/s42770-019-00145-8. [Epub ahead of print]


Inactivation of Salmonella enterica and spoilage microorganisms in orange juice treated with dimethyl dicarbonate (DMDC).

Cheng RM, Churey JJ, Worobo RW.

Int J Food Microbiol. 2018 Nov 20;285:152-157. doi: 10.1016/j.ijfoodmicro.2018.08.021. Epub 2018 Aug 22.


Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.

Yen CJ, Muro K, Kim TW, Kudo M, Shih JY, Lee KW, Chao Y, Kim SW, Yamazaki K, Sohn J, Cheng R, Zhang Y, Binder P, Mi G, Orlando M, Chung HC.

J Glob Oncol. 2018 Jul;4:1-12. doi: 10.1200/JGO.17.00227.


Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting.

Reck M, Garassino MC, Imbimbo M, Shepherd FA, Socinski MA, Shih JY, Tsao A, Lee P, Winfree KB, Sashegyi A, Cheng R, Varea R, Levy B, Garon E.

Lung Cancer. 2018 Jun;120:62-69. doi: 10.1016/j.lungcan.2018.03.025. Epub 2018 Mar 27. Review.


Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.

Chung HC, Kok VC, Cheng R, Hsu Y, Orlando M, Fuchs C, Cho JY.

Asia Pac J Clin Oncol. 2018 Jun;14(3):204-209. doi: 10.1111/ajco.12829. Epub 2018 Jan 10.


Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.

Oberdhan D, Cole JC, Krasa HB, Cheng R, Czerwiec FS, Hays RD, Chapman AB, Perrone RD.

Am J Kidney Dis. 2018 Feb;71(2):225-235. doi: 10.1053/j.ajkd.2017.08.020. Epub 2017 Nov 14.


Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW.

Muro K, Cho JY, Bodoky G, Goswami C, Chao Y, Dos Santos LV, Shimada Y, Topuzov E, Van Cutsem E, Tabernero J, Zalcberg J, Chau I, Cascinu S, Cheng R, Hsu Y, Emig M, Orlando M, Fuchs C.

J Gastroenterol Hepatol. 2018 Apr;33(4):814-824. doi: 10.1111/jgh.14007. Epub 2018 Feb 1.


The economic burden of advanced gastric cancer in Taiwan.

Hong J, Tsai Y, Novick D, Hsiao FC, Cheng R, Chen JS.

BMC Health Serv Res. 2017 Sep 16;17(1):663. doi: 10.1186/s12913-017-2609-1.


Exposure-response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.

Kim TY, Yen CJ, Al-Batran SE, Ferry D, Gao L, Hsu Y, Cheng R, Orlando M, Ohtsu A.

Gastric Cancer. 2018 Mar;21(2):276-284. doi: 10.1007/s10120-017-0737-2. Epub 2017 Jun 20.


Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.

Chen LT, Oh DY, Ryu MH, Yeh KH, Yeo W, Carlesi R, Cheng R, Kim J, Orlando M, Kang YK.

Cancer Res Treat. 2017 Oct;49(4):851-868. doi: 10.4143/crt.2016.176. Epub 2017 Jan 3. Review.


Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis.

Park JO, Ryoo BY, Yen CJ, Kudo M, Yang L, Abada PB, Cheng R, Orlando M, Zhu AX, Okusaka T.

Oncotarget. 2016 Nov 15;7(46):75482-75491. doi: 10.18632/oncotarget.12780.


Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.

Carter GC, Kaltenboeck A, Ivanova J, Liepa AM, San Roman A, Koh M, Rajan N, Cheng R, Birnbaum HG, Kim JS, Bang YJ.

Cancer Res Treat. 2017 Jul;49(3):578-587. doi: 10.4143/crt.2016.001. Epub 2016 Sep 12.


Treatment patterns in patients with advanced gastric cancer in Taiwan.

Cuyun Carter G, Kaltenboeck A, Ivanova J, Liepa AM, San Roman A, Koh M, Rajan N, Cheng R, Birnbaum H, Chen JS.

Asia Pac J Clin Oncol. 2017 Jun;13(3):185-194. doi: 10.1111/ajco.12497. Epub 2016 Apr 25.


Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer.

Muro K, Oh SC, Shimada Y, Lee KW, Yen CJ, Chao Y, Cho JY, Cheng R, Carlesi R, Chandrawansa K, Orlando M, Ohtsu A.

J Gastroenterol Hepatol. 2016 Mar;31(3):581-9. doi: 10.1111/jgh.13153.


Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States.

Schaefer CP, Cappelleri JC, Cheng R, Cole JC, Guenthner S, Fowler J, Johnson S, Mamolo C.

J Am Acad Dermatol. 2015 Oct;73(4):585-593.e3. doi: 10.1016/j.jaad.2015.06.049. Epub 2015 Aug 5.


Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned.

Lee DH, Srimuninnimit V, Cheng R, Wang X, Orlando M.

Cancer Res Treat. 2015 Oct;47(4):549-54. doi: 10.4143/crt.2014.362. Epub 2015 Apr 29. Review.


Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.

Yang JC, Ahn MJ, Nakagawa K, Tamura T, Barraclough H, Enatsu S, Cheng R, Orlando M.

Cancer Res Treat. 2015 Jul;47(3):424-35. doi: 10.4143/crt.2013.266. Epub 2014 Sep 15.


Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden.

Cole JC, Ito D, Chen YJ, Cheng R, Bolognese J, Li-McLeod J.

Health Qual Life Outcomes. 2014 Sep 4;12:114. doi: 10.1186/s12955-014-0114-3.

Supplemental Content

Loading ...
Support Center